EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes

Ping Lai, Susanne S Hille, Hariharan Subramanian, Robert Wiegmann, Pia Roser, Oliver J Müller iD, Viacheslav O Nikolaev iD, Kirstie A De Jong iD

Cardiovascular Research · 14.03.2024 · 120 (3) · 273-285

DOI: 10.1093/cvr/cvad178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 14.12.2023. Verfasst von Ping Lai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Heart Failure. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gertaud und Heinz-Rose Foundation, Chinese Scholarship Council Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Despite massive efforts, we remain far behind in our attempts to identify effective therapies to treat heart failure with preserved ejection fraction (HFpEF). Diastolic function is critically regulated by sarcoplasmic/endoplasmic reticulum (SR) calcium ATPase 2a (SERCA2a), which forms a functional cardiomyocyte (CM) microdomain where 3′,5′-cyclic adenosine monophosphate (cAMP) produced upon β-adrenergic receptor (β-AR) stimulation leads to phospholamban (PLN) phosphorylation and facilitated Ca2+ re-uptake. Methods and results To visualize real-time cAMP dynamics in the direct vicinity of SERCA2a in healthy and diseased myocytes, we generated a novel mouse model on the leprdb background that stably expresses the Epac1-PLN Förster resonance energy transfer biosensor. Mice homozygous for the leprdb mutation (db/db) developed obesity and type 2 diabetes and presented with a HFpEF phenotype, evident by mild left ventricular hypertrophy and elevated left atria filling pressures. Live cell imaging uncovered a substantial β2-AR subtype stimulated cAMP response within the PLN/SERCA2a microdomain of db/db but not healthy control (db/+) CMs, which was accompanied by increased PLN phosphorylation and accelerated calcium re-uptake. Importantly, db/db CMs also exhibited a desensitization of β1-AR stimulated cAMP pools within the PLN/SERCA2a microdomain, which was accompanied by a blunted lusitropic effect, suggesting that the increased β2-AR control is an intrinsic compensatory mechanism to maintain PLN/SERCA2a-mediated calcium dynamics and cardiac relaxation. Mechanistically, this was due to a local loss of cAMP-degrading phosphodiesterase 4 associated specifically with the PLN/SERCA2a complex.

Conclusion

These newly identified alterations of cAMP dynamics at the subcellular level in HFpEF should provide mechanistic understanding of microdomain remodelling and pave the way towards new therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Heart FailureAnimalsMiceCalciumCalcium-Binding ProteinsCyclic AMPMyocytes, CardiacSarcoplasmic ReticulumSarcoplasmic Reticulum Calcium-Transporting ATPasesStroke Volume

Stichwörter der Autor:innen

3′, 5′-Cyclic adenosine monophosphateFörster resonance energy transferHeart failure with preserved ejection fractionObesityPhosphodiesterasePhospholambanSarcoplasmic/endoplasmic reticulum calcium ATPase 2aType 2 diabetes

Substanzen

CalciumCalcium-Binding ProteinsCyclic AMPSarcoplasmic Reticulum Calcium-Transporting ATPasesAtp2a2 protein, mouse

Autor:innen und Institutionen

  • Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.
  • German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Martinistr. 52, D-20246 Hamburg, Germany.
  • Department of Cardiology, Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, First Affiliated Hospital of Gannan Medical University, 341000 Ganzhou, China.
  • Department of Internal Medicine III, University Hospital Schleswig-Holstein, University of Kiel, Arnold-Heller-Str. 3, D-24105, Kiel, Germany.
  • Department of Endocrinology and Diabetes, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg D-20246, Germany.

ORCID-Profile: Oliver J Müller, Viacheslav O Nikolaev, Kirstie A De Jong

Förderung

  • Gertaud und Heinz-Rose Foundation
  • Chinese Scholarship Council Scholarship

Zitieren

APA

Lai, P., Hille, S. S., Subramanian, H., Wiegmann, R., Roser, P., Müller, O. J., Nikolaev, V. O., & De Jong, K. A. (2024). Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes. Cardiovascular Research, 120(3), 273-285. https://doi.org/10.1093/cvr/cvad178

Vancouver

Lai P, Hille SS, Subramanian H, Wiegmann R, Roser P, Müller OJ, et al. Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes. Cardiovascular Research. 2024;120(3):273-285. doi:10.1093/cvr/cvad178

BibTeX
@article{Lai2024,
  author = {Lai, Ping and Hille, Susanne S and Subramanian, Hariharan and Wiegmann, Robert and Roser, Pia and Müller, Oliver J and Nikolaev, Viacheslav O and De Jong, Kirstie A},
  title = {Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {3},
  pages = {273--285},
  doi = {10.1093/cvr/cvad178}
}
Kostenlos starten →